Actinium Pharmaceuticals Announces New Pan-Tumor Data Demonstrating Potential Of Its Ac-225 Radiotherapy Platform Across Solid Tumors And Hematologic Malignancies; Data To Be Presented At AACR Annual Meeting On April 21